ID2 and chronic myelogenous leukemia, BCR-ABL1 positive: Interestingly, Ko et al. showed that mice transplanted with Id2–/– fetal liver cells developed leukocytosis after 6 months that resembled a myeloproliferative disorder and that overexpression of ID2 delays the onset Bcr-Abl–induced CML in vivo (77).